/주식/RZLT
RZLT

RZLT

USD

Rezolute Inc. Common Stock (NV)

$8.900-0.020 (-0.224%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$8.920

고가

$9.000

저가

$8.820

거래량

1.64M

기업 기본 정보

시가총액

808.4M

산업

생명공학

국가

United States

거래 통계

평균 거래량

1.24M

거래소

NCM

통화

USD

52주 범위

저가 $2.215현재가 $8.900고가 $10.04

관련 뉴스

Analyst Upgrades

Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $17

Citizens analyst Jason N. Butler maintains Rezolute with a Market Outperform and raises the price target from $9 to $17.

더 보기
Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $17
GlobeNewswire

Rezolute to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today

더 보기
Rezolute to Participate in Upcoming Investor Conferences
GlobeNewswire

Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today

더 보기
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)